Biosynthesis of platelet activating factor in rabbit polymorphonuclear neutrophils

Area of Science:

• Lipid metabolism
• Immunology
• Cell signaling

Background:

• Platelet activating factor (PAF) is a potent lipid mediator involved in inflammation and immune responses.
• Understanding PAF synthesis pathways is crucial for developing targeted anti-inflammatory therapies.

Purpose of the Study:

• To investigate the synthesis pathway of platelet activating factor (PAF) in rabbit peritoneal polymorphonuclear neutrophils.
• To elucidate the mechanism of PAF synthesis upon stimulation with ionophore A23187 and Ca2+.

Main Methods:

• Incubation of rabbit neutrophils with radiolabeled precursors ([3H]acetate, 1-O-[3H]alkyl-2-lyso-sn-glycero-3-phosphocholine, [14C]hexadecanol) under varying conditions (with/without ionophore A23187 and Ca2+).
• Analysis of lipid incorporation into PAF and other phosphoglycerides using radiolabeling techniques.

Main Results:

• Neutrophils incorporated [3H]acetate and 1-O-[3H]alkyl-2-lyso-sn-glycero-3-phosphocholine into PAF upon stimulation.
• Cells failed to synthesize PAF from [14C]hexadecanol, a precursor for the de novo pathway, under stimulation.
• [14C]hexadecanol incorporation was limited to phosphatidic acid during stimulation, suggesting inhibition of the de novo pathway.

Conclusions:

• Platelet activating factor (PAF) is primarily synthesized through a deacylation-reacylation mechanism in stimulated rabbit neutrophils.
• A key step in the de novo PAF synthesis pathway appears to be inhibited by ionophore A23187 and Ca2+ stimulation.
• These findings provide strong evidence for distinct regulatory mechanisms controlling PAF synthesis pathways in immune cells.